Practice
Featured experience
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
Uniti Group merger with Windstream
We are advising Uniti Group on the transaction
UMB Financial $2 billion acquisition of Heartland Financial
We are advising UMB on the acquisition and a $201.6 million stock offering
AssetMark $2.7 billion acquisition by GTCR
We are advising AssetMark on the transaction
Lightyear GP-led secondary transaction and formation of continuation fund
We advised Lightyear on the secondary transaction and continuation fund formation
White Deer GP-led secondary transaction and formation of continuation fund
We advised White Deer on the secondary transaction and $240 million continuation fund formation
Nuveen $1.25 billion senior notes offering
We advised Nuveen on the investment-grade debt offering
Perella Weinberg sale of Agility to Cerity Partners
We are advising Perella Weinberg on the transaction
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Narragansett Electric $500 million senior notes offering
We advised the company on the transaction